Eli Lilly and Company
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| LLY.BA | 0QCV.IL | BMY | BIIB | 0QYQ.IL | AZN | |
|---|---|---|---|---|---|---|
| Market cap | 9.48T | 535.73B | 131.21B | 37.61B | 215.56B | 293.14B |
| P/E (TTM) | 0.2 | 61.3 | 14.2 | 110.2 | 39.8 | 26.7 |
| Forward P/E | — | — | 9.6 | 15.6 | — | 16.7 |
| Price/book | 18.7 | 40.9 | 5.6 | 2.0 | 10.2 | 5.7 |
| Dividend yield | 0.45% | 4.05% | 3.93% | — | 3.81% | 1.69% |
| 1-year change | +68.31% | +33.33% | +32.80% | +62.24% | +38.91% | +13.30% |
| Today | +1.43% | +4.86% | +4.02% | +2.22% | +0.58% | +2.79% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.
Latest news
All LLY.BA news ›Eli Lilly: Higher Volume, Lower Realized Prices
Pharmaceutical company Eli Lilly and Company (LLY) reported volume growth of 53% last quarter against a 15% decline in realized prices. Revenue rose 39%. Gross margin went up year-over-year, too. That combination is unusual Best Stocks Now…
The One Thing To Settle Before Buying Eli Lilly Stock
Eli Lilly (LLY) is selling far more of two drugs, Mounjaro and Zepbound, than it did a year ago. The price the company collects in the U.S., however, is falling. For anyone who owns the stock, the depth of that decline is not settled. This…
Buy Max Healthcare; target of Rs 1200: Anand Rathi- Moneycontrol.com
Anand Rathi is bullish on Max Healthcare has recommended buy rating on the stock with a target price of Rs 1200 in its research report dated November 03, 2026. Buy Max Healthcare; target of Rs 1200: Anand Rathi Anand Rathi's research…
Eli Lilly widens GLP-1 lead over Novo Nordisk with nearly double the sales
Nordic Product Manager - urologi & reumatologi Clinical Trial Program Lead Faglig rådgiver til ATMP Danmark Head of Clinical Operations Territory Manager Point of Care (øst) Nordic Head of Commercial Excellence Senior Scientist / Principal…
Eli Lilly: Priced For Acceleration, Reporting Deceleration
Eli Lilly delivered strong Q3 results, but underlying growth slowed from 49% to 35% and price erosion deepened. Read more on LLY stock here. - Eli Lilly delivered strong Q3 results, but underlying growth slowed from 49% to 35% and price…
Ennature Bio Pharma Limited Lists on NSE, BSE November 4
Ennature Bio Pharma Limited listed on the National Stock Exchange of India and the Bombay Stock Exchange on November 4, 2026, with the NSE recent-listing record showing the symbol ENNATURE and a company page displaying a ₹10.00 close at…
Eli Lilly Just Delivered Another Monster Quarter. But There’s More to This Story Than Weight-Loss Drugs
Eli Lilly's weight-loss drugs get all the headlines, but CEO David Ricks is betting the company's next act looks nothing like its last one. Here is what it would actually take for shares to reach $1,700 in 2027. Eli Lilly (NYSE:LLY | LLY…
Celltrion Unveils World’s First Quadruple-Agonist Obesity Drug Candidate, CT-G32/SCO-940
Celltrion has unveiled preclinical data for CT-G32/SCO-940, a next-generation obesity drug candidate designed to simultaneously target four hormonal pathways: GLP-1, GIP, glucagon and amylin. The company aims to advance the candidate into…
Forget Nvidia: Eli Lilly Will Become “the Most Valuable Company in the World,” Says Macro Investor
Erik Flyg from Bloomberg and Sergei Starostin from Pexels via Canva Eli Lilly (LLY) hit a record high on Friday, and it’s now worth about $1.1 trillion, as much as Berkshire Hathaway. The rally came after a monster quarter. Third-quarter…
Lilly Surges As Its Drugs Melt Pounds. Among 16 New To Best Stock Lists
Worked nearly 18 years until 2016 as a full-time reporter/copy editor with Investor's Business Daily, a leading business news company. Contributing writer for Forbes.com for a year and a half before returning to IBD. Currently a full-time…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com247
- themarketsdaily.com110
- seekingalpha.com78
- fool.com69
- theglobeandmail.com63
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.